ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

IMMX Immix Biopharma Inc

2.45
0.10 (4.26%)
시간외 거래
최종 업데이트: 06:17:14
15분 지연
기업명 주식 심볼 시장 주식 타입
Immix Biopharma Inc IMMX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.10 4.26% 2.45 06:17:14
개장가 저가 고가 종가 전일 종가
2.35 2.26 2.50 2.33 2.35
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/02/202407:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/02/202423:09EDGAR2Form 8-K - Current report
06/02/202406:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/02/202406:37EDGAR2Form 8-K - Current report
13/12/202308:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202300:48IHNWImmix Biopharma Announces FDA Approval of IND Application..
10/11/202309:57EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
26/09/202305:15EDGAR2Form S-3 - Registration statement under Securities Act of..
19/09/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/09/202307:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202305:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202305:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
24/08/202305:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/08/202305:05EDGAR2Form 8-K - Current report
15/08/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202305:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/07/202321:42GLOBEImmix Biopharma Subsidiary Nexcella Announces NXC-201..
17/07/202322:37GLOBEImmix Biopharma Reports 2nd Positive Interim Clinical Trial..
15/07/202306:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/07/202306:26EDGAR2Form 8-K - Current report
10/07/202322:47GLOBEImmix Biopharma Subsidiary Nexcella Completes Initial..
26/06/202322:49GLOBEImmix Biopharma Subsidiary Nexcella Completes Pre-IND..
22/06/202322:53GLOBEImmix Biopharma Subsidiary Nexcella Appoints Edward J...
20/06/202322:45GLOBEImmix Biopharma Subsidiary Nexcella Appoints Jeffrey H...
16/06/202322:43GLOBEImmix Biopharma Subsidiary Nexcella Appoints Mary Sue..
14/06/202320:30GLOBEImmix Biopharma Completes $5 Million At-The-Market Equity..
12/06/202322:49GLOBEImmix Biopharma Subsidiary Nexcella Appoints Henry..
26/05/202322:53GLOBEImmix Biopharma Subsidiary Nexcella Announces Commencement..
22/05/202305:05GLOBENexcella Announces Positive NXC-201 Clinical Results at..
22/05/202305:00GLOBEImmix Biopharma Announces Positive NXC-201 Clinical Results..

최근 히스토리

Delayed Upgrade Clock